老虎证券

BRIEF-Allarity Therapeutics Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027

Reuters
04-01
BRIEF-Allarity <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027

Allarity Therapeutics Inc ALLR.O:

  • ALLARITY THERAPEUTICS: CASH & CASH RECEIVABLE BALANCE OF $20.9 MILLION AS OF DEC 31, EXPECTED TO FUND OPERATIONS, INCLUDING CLINICAL ACTIVITIES INTO 2027

  • ALLARITY THERAPEUTICS: ENROLLMENT IN NEW PHASE 2 SCLC TRIAL TO BEGIN IN Q2-Q3 2025, FULLY FUNDED BY U.S. VETERANS ADMINISTRATION

Source text: ID:nGNX6nrXZ8

Further company coverage: ALLR.O

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10